PubRank
Search
About
Bernd Döhler
Author PubWeight™ 62.17
‹?›
Top papers
Rank
Title
Journal
Year
PubWeight™
‹?›
1
Antibodies against MICA antigens and kidney-transplant rejection.
N Engl J Med
2007
5.31
2
Lymphomas after solid organ transplantation: a collaborative transplant study report.
Am J Transplant
2004
3.25
3
Multicenter analysis of kidney preservation.
Transplantation
2007
2.39
4
C3 polymorphisms and allograft outcome in renal transplantation.
N Engl J Med
2009
2.29
5
Cardiovascular death in kidney recipients treated with renin-angiotensin system blockers.
Transplantation
2014
1.96
6
H-Y as a minor histocompatibility antigen in kidney transplantation: a retrospective cohort study.
Lancet
2008
1.85
7
Long-term prospective study of steroid withdrawal in kidney and heart transplant recipients.
Am J Transplant
2005
1.78
8
The effect of donor gender on graft survival.
J Am Soc Nephrol
2002
1.72
9
No association of kidney graft loss with human leukocyte antigen antibodies detected exclusively by sensitive Luminex single-antigen testing: a Collaborative Transplant Study report.
Transplantation
2011
1.67
10
Pediatric kidney transplantation: analysis of donor age, HLA match, and posttransplant non-Hodgkin lymphoma: a collaborative transplant study report.
Transplantation
2010
1.60
11
Effect of cytomegalovirus prophylaxis with immunoglobulin or with antiviral drugs on post-transplant non-Hodgkin lymphoma: a multicentre retrospective analysis.
Lancet Oncol
2007
1.51
12
Prolongation of long-term kidney graft survival by a simultaneous liver transplant: the liver does it, and the heart does it too.
Transplantation
2002
1.48
13
Impact of HLA compatibility on lung transplant survival and evidence for an HLA restriction phenomenon: a collaborative transplant study report.
Transplantation
2010
1.42
14
Kidney graft survival in Europe and the United States: strikingly different long-term outcomes.
Transplantation
2013
1.36
15
Improved long-term outcomes after renal transplantation associated with blood pressure control.
Am J Transplant
2005
1.18
16
Disassociation between risk of graft loss and risk of non-Hodgkin lymphoma with induction agents in renal transplant recipients.
Transplantation
2006
1.11
17
Three-year outcomes following 1420 ABO-incompatible living-donor kidney transplants performed after ABO antibody reduction: results from 101 centers.
Transplantation
2015
1.05
18
No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report.
J Am Soc Nephrol
2006
1.05
19
Influence of time of rejection on long-term graft survival in renal transplantation.
Transplantation
2008
1.04
20
Effect of human leukocyte antigen compatibility on kidney graft survival: comparative analysis of two decades.
Transplantation
2007
1.03
21
Metabolic control improves long-term renal allograft and patient survival in type 1 diabetes.
J Am Soc Nephrol
2008
1.02
22
Epidemiology of pretransplant EBV and CMV serostatus in relation to posttransplant non-Hodgkin lymphoma.
Transplantation
2009
1.02
23
Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report.
Am J Transplant
2004
1.01
24
Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant.
Transplantation
2008
1.00
25
Inosine monophosphate dehydrogenase polymorphisms and renal allograft outcome.
Transplantation
2012
0.99
26
Influence of immunosuppressive regimens on graft survival and secondary outcomes after kidney transplantation.
Transplantation
2009
0.99
27
Donor ABCB1 variant associates with increased risk for kidney allograft failure.
J Am Soc Nephrol
2012
0.98
28
Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
Hum Immunol
2009
0.93
29
HLA antibodies and the occurrence of early adverse events in the modern era of transplantation: a collaborative transplant study report.
Transplantation
2009
0.91
30
Impact of HLA mismatching on incidence of posttransplant non-hodgkin lymphoma after kidney transplantation.
Transplantation
2010
0.89
31
HLA matching and kidney transplantation: beyond graft survival.
Clin Transpl
2013
0.88
32
Genotypic diversity of complement component C4 does not predict kidney transplant outcome.
J Am Soc Nephrol
2010
0.86
33
Risks of allogeneic hand transplantation.
Microsurgery
2004
0.84
34
Increased pretransplantation plasma kynurenine levels do not protect from but predict acute kidney allograft rejection.
Hum Immunol
2010
0.83
35
Association of Kidney Graft Loss With De Novo Produced Donor-Specific and Non-Donor-Specific HLA Antibodies Detected by Single Antigen Testing.
Transplantation
2015
0.82
36
The collaborative transplant study registry.
Transplant Rev (Orlando)
2013
0.81
37
Identification of highly responsive kidney transplant recipients using pretransplant soluble CD30.
J Am Soc Nephrol
2002
0.81
38
Analysis of positive kidney, heart, and liver transplant crossmatches reported to the Collaborative Transplant Study.
Hum Immunol
2009
0.81
39
Transplantation of the type 1 diabetic patient: the long-term benefit of a functioning pancreas allograft.
Clin J Am Soc Nephrol
2010
0.81
40
VEGF 936 C/T gene polymorphism in renal transplant recipients: association of the T allele with good graft outcome.
Hum Immunol
2007
0.80
41
Posttransplant sCD30 as a predictor of kidney graft outcome.
Transplantation
2011
0.79
42
Natural killer-cell receptor polymorphisms and posttransplantation non-Hodgkin lymphoma.
Blood
2010
0.79
43
Soluble CD30 as a predictor of kidney graft outcome.
Transplantation
2002
0.79
44
Association of mismatches for HLA-DR with incidence of posttransplant hip fracture in kidney transplant recipients.
Transplantation
2011
0.78
45
Influence of Current and Previous Smoking on Cancer and Mortality After Kidney Transplantation.
Transplantation
2016
0.78
46
Deleterious impact of mismatching for human leukocyte antigen-C in presensitized recipients of kidney transplants.
Transplantation
2011
0.77
47
Deleterious impact of HLA-DRB1 allele mismatch in sensitized recipients of kidney retransplants.
Transplantation
2013
0.77
48
Reduced rate of cardiovascular death after cytomegalovirus prophylaxis in renal transplant recipients.
Transplantation
2015
0.77
49
Does borderline kidney allograft rejection always require treatment?
Transplantation
2010
0.76
50
The role of pretransplant dialysis modality on renal allograft outcome.
Nephrol Dial Transplant
2011
0.76
51
Renin-Angiotensin system blockers and cardiovascular death in kidney recipients.
Transplantation
2014
0.75
52
Response to A reassessment of the Survival Advantage of Simultaneous Kidney-Pancreas Versus Kidney-Alone Transplantation.
Transplantation
2015
0.75
53
HLA Matching in Pediatric Kidney Transplantation: HLA Poorly Matched Living Donor Transplants Versus HLA Well Matched Deceased Donor Transplants.
Transplantation
2017
0.75
54
Association of single nucleotide polymorphisms on chromosome 9p21.3 with cardiovascular death in kidney transplant recipients.
Transplantation
2013
0.75
55
Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.
Nephrol Dial Transplant
2012
0.75
56
High Posttransplant Cancer Incidence in Renal Transplanted Patients With Pretransplant Cancer.
Transplantation
2017
0.75
57
Genetic polymorphisms of adhesion molecules and kidney transplant survival.
Transplantation
2010
0.75
58
Association of pretransplant soluble glycoprotein 130 (sgp130) plasma levels and posttransplant acute tubular necrosis in renal transplant recipients.
Transplantation
2009
0.75